Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Inflamm Bowel Dis. 2017 Feb;23(2):181–191. doi: 10.1097/MIB.0000000000001009

Table 2.

Comparison of design features of dietary intervention and drug trials

Dietary intervention trials Drug trials
Patient population Often children Typically adults first and children studied only after efficacy established in adults
Inclusion and exclusion criteria Often exclude underweight or malnourished; May exclude those whose usual diet is similar to intervention diet Nutrition or usual diet rarely part of inclusion criteria
Common outcomes Disease activity, quality of life, anthropometric parameters Disease activity, quality of life
Concomitant medications Determined by study question May exclude certain medications to avoid excessive immunosuppression
Intervention Supplementation or exclusion of a dietary component Addition or withdrawal of a medication
Comparator Placebo if studying supplement; usual or standard diet if studying dietary pattern Placebo or effective therapy
Randomization Essential Essential
Blinding Sometimes impossible Essential
Dose finding Uncommon Based on phase 1 and 2 trials
Sample size Based on minimally important difference Based on minimally important difference
Adherence measurement 24 hour recalls, food frequency questionnaires, food checklists, and or measurement of biomarkers Pill counts, electronic monitoring, direct observation therapy
Analytic approach Intention to treat analysis, with or without additional per protocol analysis Intention to treat analysis
Personnel May include plant scientists, food scientists, registered dietitians, educational experts, behavior interventionists May include experts in pharmacodynamics and pharmacokinetic measurements